New Alzheimer's drug hailed as 'beginning of the end' in search for treatment
Lecanemab was found to slow decline in patients’ memory and thinking.
Source: wimbledonguardian.co.uk
Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab was found to slow decline in patients’ memory and thinking.
Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain
Lecanemab was found to slow decline in patients’ memory and thinking.
Lecanemab was found to slow decline in patients’ memory and thinking.
Findings of a phase-three clinical trial confirm it slows cognitive decline by 27 per cent in sufferers